Overview
Appreciated for his strategic analysis and solutions that fit each client’s specific needs, Jason Jardine represents a diverse clientele in all aspects of intellectual property acquisition, protection and enforcement across the U.S. and abroad. Amiable, easy-going, flexible and smart, Jason is sensitive to his client’s bottom line and seeks to diligently conserve their resources at every turn. Clients appreciate not only that Jason’s practice is truly multi-faceted, but also that he is absolutely committed to achieving their objectives and financial goals.
Jason’s clients include fast-growth and emerging companies seeking to acquire their first patent, which is usually the most difficult to obtain, as well as middle market and major corporations with thousands of IP assets and multiple families of patents. Jason’s clients are international in scope, with special attention to California and Arizona businesses. Jason focuses on helping to acquire patents, including patent prosecution, planning and advice related to infringement. Jason also advises on the acquisition and enforcement of trademarks and copyrights, prepares infringement and invalidity studies, and navigates clients through and beyond licensing and the IP due diligence issues that permeate M&A activity.
Notably, Jason is particularly skilled in taking distressed patents that are languishing at the USPTO and getting them approved, launched, leveraged and/or sold. Jason is known for succeeding where other lawyers and law firms have fallen short. A testament to those he serves, Jason has maintained client relationships that have spanned more than a decade. A “vision whisperer” with one client noting his work as an “an answer to a prayer,” Jason’s ability to analyze his client’s competition and realize the right result allow him to design long- and short-term IP and brand development strategies grounded in law and practical business sense.
Jason’s experience spans the full range of life science disciplines, including biotechnology, pharmaceuticals, neutraceuticals and medical devices, and also chemistry, clean technology and hydrogen fuel cells, semiconductors, metal works/mining, action sports and fashion. He is also skilled in the area of computer science inventions related to hospital and emergency data management and the gamification of data.
Nominated a “top attorney” in San Diego County, Jason served as the San Diego Chapter Chair of the Licensing Executives Society and as a mentor for the Center for Entrepreneurial Innovation (CEI) and the Northern Arizona Center for Entrepreneurship and Technology (NACET). He is a frequent speaker at the World Life Sciences Conference of the International Bar Association (IBA) on IP topics and a sponsor and presenter at San Diego Fashion Week on branding and IP protection. An officer on the Intellectual Property and Entertainment Law Committee of the IBA, Jason regularly contributes to the firm’s Life Science and
Fashion blogs.
Clerk Experience
Clerk for the Honorable G. Murray Snow, Arizona Court of Appeals
Education
- Brigham Young University (J.D., 2004)
- Brigham Young University (B.S. Chemistry, 2001), Minors in Physics and Mathematics
Recognition
Awards & Honors
- Recognized for outstanding work in patent law in the 2024 edition of the Intellectual Asset Management (IAM) “Patent 1000 Guide” for Prosecution (2024)
- Recognized by The Legal 500 “United States” for Patent Prosecution in 2024
- Recognized as one of “The World’s Leading Patent Professionals” in Prosecution for 2020-2023 by IAM Patent 1000. The 2021 guide noted Jardine is “appreciated for the creativity with which he pursues the registration of applications that have got stuck in the system under other counsel.” The 2022 guide recognized him as someone who “does a sterling job of tailoring his advice to different audiences, including start-ups and market leaders.” In 2023, he was described as “a prosecution master,” and someone who “effectively navigates difficult patent eligibility issues to secure vital rights for his following, and paves the way to their success in future ventures.”
- Recognized by The Legal 500 for Patent Licensing in 2019 and Patent Prosecution in 2023
- Outstanding Young Attorney Nominee 2011, The Daily Transcript
- Order of the Barristers
Affiliations
San Diego Licensing Executives Society
American Chemical Society
J. Reuben Clark Law Society
Phi Delta Phi Legal Fraternity
Board Member of AZ BioIndustry Association (AZBio)
Officer of Intellectual Property and Entertainment Law Committee of International Bar Association (IBA)
Member NuFund Venture Group
News & Insights
Articles
Co-author, “35 U.S.C. § 101 Hurdles for Obtaining and Enforcing Nutraceutical Patents,” American Intellectual Property Association (January 31, 2023)
Co-author, “Intellectual property and access to vaccines during the Covid-19 pandemic,” International Bar Association (July 6, 2021)
Quoted in, “U.S. doubles down on protecting university research from China,” Reuters (February 28, 2021)
Quoted in, “Covid-19: fledgling vaccination programmes leave poorer nations and vulnerable groups behind,” Market Screener (February 9, 2021)
Quoted in, “Claim patents are stopping poorer countries from getting Covid-19 vaccines is Half True,” The Ferret (February 2, 2021)
Author, “Patent Eligibility for Nutraceutical & Cosmetic Companies,” Nutrition Industry Executive (December 1, 2020)
Co-Author, Compulsory patent licensing in the era of pandemic, IBA Intellectual Property and Entertainment Law Committee e-bulletin (June 2020)
Co-Author, Government Appropriation of Patent Rights, BioProcess International (May 26, 2020)
Co-Author, “Intellectual Property in Nutraceuticals: Patents, Trademarks, and Trade Secrets,” Nutritional Outlook (August 14, 2018)
Biotechnology Blog
- End of an Era: The After Final Consideration Pilot Program 2.0 Concludes
- Settlements Don’t Close the Door: Antitrust Claims Follow IPR Challenges in Life Sciences
- FDA Approves Colony Stimulating Factor-1 Receptor (Csf-1R) Blocking Antibody for Treatment of Chronic Graft-Versus-Host Disease (Cgvhd)
- Understanding the Dangers of Counterfeit Drugs Through the Lens of Fake Ozempic
- FDA Panel Votes Against MDMA-Assisted Talk Therapy
- Medicare Drug Price Negotiation Program Steadily Progressing Despite Lawsuits
- Introduced Patent Eligibility Restoration Act of 2023 (PERA) Seeks to Revitalize Patent Eligibility Standards
- The First FDA Approved, Chinese Developed, PD-1 Inhibitor For Nasopharyngeal Carcinoma
- FDA Approves Generic Fluorescein Injection
- Recessions and Patent Applications: Navigating the Ups and Downs of the Innovation Economy
- A Patent for Controlling Access to Drugs Is Not Listable in the Orange Book
Speeches & Seminars
“Protecting your innovations, intellectual property essentials: provisional and PCT strategies” AZ Bio PEERS Program, webinar, June 18, 2024.
“Securing innovation: Tackling the 21st century epidemic of counterfeiting and intellectual property piracy”, International Bar Association World Life Sciences Conference, Roundtable Discussion, May 29, 2024.
“Why Patents Are Important” San Diego Inventor’s Forum, Presentation, March 14, 2024
“Legal Issues in a Fashion-related Startup” San Diego Mesa College, Presentation, March 8, 2024
“How to prepare an intellectual property portfolio for licensing” AZ Bio PEERS Program, Panel discussion, October 22, 2023
“Patents in the U.S. v. Rest of the World”, International Bar Association World Life Sciences Conference, Roundtable Discussion, June 1, 2023.
“Munch on This! Insights into IP and Regulatory Issues Surrounding Nutritional Products in the U.S. and Beyond”, American Intellectual Property Association Mid-Winter Institute, Panel Discussion, February 2, 2023.
“Going Green – Protecting and Encouraging Green Technology Innovation with IP”, International Bar Association Silicon Beach Conference: From Start-Up to Exit Conference, Roundtable Discussion, January 23, 2023.
“Commandments for University Spin-Out Companies” San Diego Intellectual Property Law Association, Presentation, November 10, 2022.
“Underutilized Procedural Methods for Getting Patents Allowed in the U.S. and Europe and India”, International Bar Association Conference, Roundtable Discussion, October 31, 2022.
“Compulsory Licensing or Competition Arrangements: A New Way to Access Medicines and Vaccines”, International Bar Association World Life Sciences Conference, Panel Discussion, June 4, 2022.
“AI in Drug Discovery and Clinical Trials”, International Bar Association World Life Sciences Conference, Roundtable Discussion, June 3, 2022.
“Patents in a pandemic”: Patent waivers, compulsory licences, do they assist access to a vaccine?. International Bar Association, Roundtable Discussion, November 4, 2021.
“Have patents cured Covid-19?”, Berlin Conference of the International Bar Association, Panel Discussion, October 11, 2021.
“Five Commandments for University Spin-out Companies”, IGE MedTech Accelerator at University of California San Diego (UCSD), April 21, 2021.
“Intellectual Property 101 in Four Lectures”, Arizona State University, April 2021.
“Do patent rights assist in getting a vaccine or cure faster of hinder the process, with a specific eye on the current pandemic.” International Bar Association Conference, Roundtable Discussion, November 2020.
“Patent Considerations”, Famela & Friends, Radio Interview, September 26, 2020.
“Intellectual Property Considerations for Designers & Artists” San Diego Fashion Week, Zoom Presentation, June 4, 2020.
“Provisional and PCT Filing Strategies” Arizona Bioindustry Association PEERS, Presentation, February 18, 2020.
“Extreme Pressure”: Forced changes to Intellectual Property laws as the price of free trade. International Bar Association Conference, Roundtable Discussion, September 21, 2019.
Social media: connecting patients and medical centres – the opportunities, risks and realities, International Bar Association World Life Sciences Conference, Roundtable Discussion, May 2019
Relevant effects of international and multilateral treaties on Life Sciences industry, International Bar Association World Life Sciences Conference, Panel Discussion, May 2019
Your eBook, your game, your drone? You probably don’t own it!, Annual Conference of the International Bar Association, Panel Discussion, October 2018
Reproductive issues and the law, IBA World Life Sciences Conference, Roundtable Discussion, June 2018
Market access in life sciences: Orphan Drugs, IBA World Life Sciences Conference, Panel Discussion, June 2017
Following Brexit and Trump: will international medical device regulations change?, IBA World Life Sciences Conference, Roundtable Discussion, June 2017
Orphan drugs – regulatory framework in the US and EU and proposed schemes for Japan, Australia and other countries, IBA World Life Sciences Conference, Roundtable Discussion, June 2016
Patent-eligibility of nature-based products – Myriad and its aftermath, IBA World Life Sciences Conference, Roundtable Discussion, June 2015
Revised Myriad Guidance from the US Patent and Trade Office (USPTO) – Now What is Patentable?, BIO Pacific Rim Summit on Industrial Biotechnology and Bioenergy, Panel Discussion, December 2014.
The Legalities of Fashion – Intellectual Property Workshop, Fashion Week San Diego, Panel Discussion, September 2013, May 2014, March 2016, September 2017, and September 2018.
Growing Technology in Arizona: Celebrating Success in Medical and Bioscience, Arizona Technology Council and Arizona Commerce Authority, Panel Discussion, October 2012.
Effective Utilization of Patent Searches in the Wake of AIA Patent Reform Act, Licensing Executives Society Winter Meeting, Panel Discussion, March 2012.
What Every Small Business Banker Should Know About Patents, Presentation to Arizona Small Business Bankers, November 2011.